Authors
Loading...
Randomized trial predicts PD-L1 expression in NSCLC patients, suggesting a tool for personalized treatment decisions.
Lu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: